Therapy management systems, methods, and devices

Patent metadata

Field	Value
Publication number	US-12364822-B2
Application number	US-202217806898-A
Country	US
Kind code	B2
Filing date	Jun 14, 2022
Priority date	Dec 12, 2017
Publication date	Jul 22, 2025
Grant date	Jul 22, 2025

Abstract

One or more embodiments of the disclosure are related, generally, to a reusable accessory for a manual medication delivery device. Such a reusable accessory may include a wireless communication interface, a detection circuitry, and a recommendation system. In one or more embodiments, an adapter may be configured to reversibly couple such a reusable accessory to a manual medication delivery device. Dosing events may be detected that are associated with dosing at the manual medication delivery device. Dose recommendations may be provided responsive to analyte measurements and/or dosing events.

First claim

What is claimed is:

1. An accessory for an insulin pen, the accessory comprising:
at least one display; and
a controller comprising:
at least one processor; and
at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause one or more regions of the at least one display to indicate whether a time period since a dosing event associated with the insulin pen has exceeded a first threshold period of time.

2. The accessory of claim 1 , wherein the dosing event comprises at least one of an attaching of the accessory to or a detaching of the accessory from the insulin pen.

3. The accessory of claim 1 , wherein causing the one or more regions of the at least one display to indicate that the time period since the dosing event has exceeded the first threshold period of time comprises changing an appearance of the one or more regions from a first appearance to a second appearance.

4. The accessory of claim 3 , further comprising instructions that, when executed by the at least one processor, cause the one or more regions of the at least one display, responsive to the accessory being attached to or detached from the insulin pen for a second threshold period of time, to change an appearance of the one or more regions of the at least one display from the second appearance to a third appearance.

5. The accessory of claim 4 , wherein the first threshold period of time comprises one of 6 hours or 12 hours.

6. The accessory of claim 5 , wherein the second threshold period of time comprises one of 9 hours or 21 hours.

7. The accessory of claim 3 , wherein changing the appearance of the one or more regions of the at least one display from the first appearance to the second appearance comprises changing a color of the one or more regions of the at least one display.

8. The accessory of claim 3 , wherein the first appearance of the one or more regions of the at least one display indicates that an insufficient amount of time has passed since a previous dosing action inferred from the dosing event to warrant an additional dose.

9. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to:
responsive to the accessory being attached to or detached from the insulin pen for at least a third threshold period of time, automatically identify a dosing event; and
communicate dosing data to a remote device.

10. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to:
responsive to the accessory being attached to or detached from the insulin pen for less than a third threshold period of time, determine that a dosing event has not occurred;
responsive to a manual user override action, associate a dosing event with a period of time for which the accessory was attached or detached; and
communicate dosing data to a remote device associated with the dosing event.

11. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to:
receive a manual input indicating a dosing event; and
communicate dosing data to a remote device associated with the dosing event.

12. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to cause the one or more regions of the at least one display to represent a percentage of active insulin remaining within a user based on a time of the dosing event and a current time.

13. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to:
determine an amount of insulin remaining in the insulin pen;
determine a dose amount and time associated with the dosing event; and
cause the one or more regions of the at least one display to represent an estimation of active insulin remaining within a user based on a current time and the time and dose amount associated with the dosing event.

14. The accessory of claim 1 , wherein the accessory comprises a pen cap.

15. The accessory of claim 1 , further comprising an adapter configured to couple the accessory to the insulin pen.

16. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to receive glucose data from a glucose monitor.

17. The accessory of claim 16 , further comprising instructions that, when executed by the at least one processor, cause the controller to automatically display the received glucose data.

18. The accessory of claim 1 , wherein the accessory is configured to be utilized with one or more of a long-acting insulin pen or a rapid-acting insulin pen.

19. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to receive patient-specific therapy parameters from one or more of an application operating on a remote device or manually.

20. The accessory of claim 19 , wherein the patient-specific therapy parameters comprise one or more of dose parameters or timing parameters.

21. The accessory of claim 19 , wherein the patient-specific therapy parameters are received from a healthcare provider device.

22. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to communicate dosing event data to an application on a remote device.

23. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to communicate dosing event data to an application on a remote device via a BLUETOOTH communication protocol.

24. The accessory of claim 1 , further comprising instructions that, when executed by the at least one processor, cause the controller to wirelessly pair the accessory with a remote device.

25. A pen cap for an insulin delivery device comprising:
at least one display; and
a controller comprising:
at least one processor; and
at least one non-transitory computer-readable storage medium storing instructions thereon that, when executed by the at least one processor, cause the at least one display to indicate information associated with one or more of motion or lack of motion of the pen cap.

26. The pen cap of claim 25 , further comprising instructions that, when executed by the at least one processor, cause the controller to:
detect motion of the pen cap; and
responsive to the pen cap being motionless for at least a first threshold period of time, change an appearance of the at least one display from a first appearance to a second appearance.

27. The pen cap of claim 26 , further comprising instructions that, when executed by the at least one processor, cause the controller to, responsive to the pen cap being attached to or detached from the insulin delivery device for a second threshold period of time, change an appearance of the at least one display from the second appearance to a third appearance.

28. The pen cap of claim 27 , wherein the first threshold period of time comprises one of 6 hours or 12 hours.

29. The pen cap of claim 28 , wherein the second threshold period of time comprises one of 9 hours or 21 hours.

3

Assignees

• Bigfoot Biomedical Inc

Inventors

• Sjolund John
• Srinath Ambika
• Bochenko Andrew
• Crothall George
• Mazlish Bryan
• Block Jennifer Martin
• Matarese Sarah
• Mackowiak Linda
• Desborough Lane

Classifications

• A61M2205/3306

  Optical measuring means · CPC title

• A61M2005/2006

  Having specific accessories · CPC title

• A61M5/003

  Kits for diabetics · CPC title

• A61B5/746

  Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms · CPC title

• A61B5/7455

  characterised by tactile indication, e.g. vibration or electrical stimulation · CPC title